August 28, 2016 2:47 AM ET

Biotechnology

Company Overview of Cancer Genetics, Inc.

Executive Profile

Charles M. Rudin M.D., Ph.D.

Member of Scientific Advisory Board, Cancer Genetics, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 2 different industries.

See Board Relationships
----

Background

Mr. Charles M. Rudin M.D., Ph.D. serves as the Chief of the Thoracic Oncology Service at Memorial Slone Kettering Cancer Center specializing in the care of patients with lung cancer. Mr. Rudin serves as a Sidney Kimmel Cancer Center Director of Lung Cancer Therapeutics Program. Dr. Rudin is Specialist in small cell lung cancer, novel oncology agent clinical trials and Lead investigator in virotherapy (Onyx-015) trials. He serves as a Member of Scientific Advisory Board ...

Corporate Headquarters

201 Route 17 North
Rutherford, New Jersey 07070

United States

Phone: 201-528-9200
Fax: 201-528-9201

Board Members Memberships

There is no Board Members Memberships data available.

Education

PhD
The University of Chicago
MD
University Of Chicago - Pritzker School Of Medicine

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jack E. Stover CPAChief Executive Officer, President and Director
Interpace Diagnostics Group, Inc.
$8.1K
Kenneth A. Berlin Chief Executive Officer and President
Rosetta Genomics, Ltd.
$875.0K
William J. Welch M.B.A.Chief Executive Officer and Director
TrovaGene, Inc.
--
Bonnie H. Anderson Co-Founder, Chief Executive Officer, President, Director and Member of Non-Management Equity Award Committee
Veracyte, Inc.
$457.0K
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Cancer Genetics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.